Discovery, Regulated, and High Throughput Small Molecule Bioanalysis Services

As one of the largest bioanalytical LC/MS/MS service providers in the U.S., we specialize in developing and validating robust bioanalytical methods for the quantification of API and metabolites in various biological matrices, using LC/MS/MS (HPLC, UPLC, 2-D chromatography), HPLC/UV, and HPLC/Fluorescence techniques. We provide industry-leading small molecule bioanalysis for drug development.

Discovery Bioanalysis (non-GLP)

Non-GLP bioanalysis and pharmacokinetic (PK) screening, to assist with lead candidate selection decisions and to support discovery PK and early preclinical studies.

Methods can later be adapted and validated for regulated preclinical and clinical studies.

High-Throughput Bioanalysis

For sponsors needing high-throughput bioanalysis of clinical study samples, we have 25 LC/MS/MS systems, most coupled with UPLC systems, and the capacity to inject at least six plates of samples unattended.

Pharmacokinetic Analysis & Reports

Method Development & Validation for Small Molecule Bioanalysis

We provide full method development and validation for the analysis of small molecules. Our scientists approach every compound with creativity, innovation, and years of scientific knowledge, allowing us to uncover solutions to complex bioanalytical challenges.

Specimen Collection Kits

MicroConstants assembles and distributes protocol-specific specimen collection kits to simplify and streamline the PK collection process for single and multi-site clinical trials. Kits are tailored to your specific sampling needs and can be shipped worldwide. The specimen samples collected can be returned to the testing laboratory of your choice for small molecule bioanalysis.

Ready to Start Your Project? Have a Question?

Our scientists are available to discuss how our bioanalytical CRO can help you streamline the drug development process through specialized expertise in regulated bioanalysis, DMPK, and pharmacokinetic analysis.